Position in GRAL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,681,353
+$1,142,538 QoQ
Shares Held
24,628
+136.2% QoQ
Ownership
0.055%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#92
of 374 holders
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0%
Shared 64%
None 36%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026AMERIPRISE FINANCIAL INC holds $3,403,585,552 across 30 Diagnostics & Research names. GRAL ranks #25 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
1,547,342 | $775,775,381 | |
| 2 | GH |
Guardant Health, Inc.
|
3,150,897 | $472,729,076 | |
| 3 | DHR |
Danaher Corp /De/
|
2,331,466 | $444,097,640 | |
| 4 | ILMN |
Illumina, Inc.
|
1,148,102 | $201,870,770 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
881,189 | $199,844,850 | |
| 6 | ICLR |
Icon PLC
|
979,596 | $170,165,619 | |
| 7 | WAT |
Waters Corp /De/
|
436,388 | $163,662,953 | |
| 8 | DGX |
Quest Diagnostics Inc
|
759,975 | $161,076,698 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,681,353 | 24,628 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $538,815 | 10,426 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,510,558 | 41,016 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $620,450 | 10,493 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $261,830 | 5,092 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $383,074 | 14,999 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $680,834 | 38,142 | Shares | Defined | 2025-02-14 | |
| 2024-06-30 | $456,749 | 29,717 | Shares | Defined | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||